Phibro Animal Health (PAHC) Revenue (2012 - 2026)

Phibro Animal Health's Revenue history runs 15 years deep, the most recent figure standing at $383.5 million for Q1 2026.

• On a quarterly basis, Revenue rose 10.27% year-over-year to $383.5 million in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 25.98% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 27.37% from the prior year.
• Revenue climbed to $383.5 million in Q1 2026 per PAHC's latest filing, from $373.9 million in the prior quarter.
• Across five years, Revenue topped out at $383.5 million in Q1 2026 and bottomed at $231.3 million in Q3 2023.
• The 5-year median for Revenue is $260.4 million (2024), against an average of $288.7 million.
• Across the five-year window, Revenue retreated 0.5% in 2023 and jumped 39.73% in 2025, its largest moves.
• Year by year, Revenue stood at $244.6 million in 2022, then rose by 2.17% to $249.9 million in 2023, then advanced by 23.73% to $309.3 million in 2024, then advanced by 20.9% to $373.9 million in 2025, then rose by 2.58% to $383.5 million in 2026.
• Per Business Quant, the three latest PAHC Revenue figures stand at $383.5 million (Q1 2026), $373.9 million (Q4 2025), and $363.9 million (Q3 2025).